Table 5.

The incidence of hematological toxicity.

		Treatment group (n = 36)			Control group (n = 36)
		Grade 0	Grade 1 or 2	Grade 3 or 4	Grade 0	Grade 1 or 2	Grade 3 or 4	P value
Leukocytes	Cycle 1	33 (91.7%)	2 (5.6%)	1 (2.8%)	27 (84.4%)	5 (15.6%)	0	.352
	Cycle 2	30 (83.3%)	6 (16.7%)	0	24 (75.0%)	5 (15.6%)	3 (9.4%)	.396
Hemoglobin	Cycle 1	18 (50.0%)	18 (50.0%)	0	21 (65.6%)	11 (34.4%)	0	.193
	Cycle 2	17 (47.2%)	18 (50.0%)	1 (2.8%)	15 (46.9%)	17 (53.1%)	0	.977
Platelet	Cycle 1	35 (97.2%)	1 (2.8%)	0	30 (93.8%)	2 (6.3%)	0	.486
	Cycle 2	35 (97.2%)	1 (2.8%)	0	23 (71.9%)	8 (25.0%)	1 (3.1%)	.003